Belinda Lovelace, PharmD, MS, MJ

Senior Director, Heath Economics and Outcomes Research
F2G, Inc.

Disclosure(s): F2G, Inc.: Employee

Poster(s):

• (P-907) Burden of Hospitalization for Coccidioidal Meningitis: A National Cohort Study
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-911) Antifungal Treatment Patterns, Healthcare Utilization, Costs and Mortality in Coccidioidal Meningitis Patients: A Descriptive Analysis of United States Nationwide Claims Database
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1010) Clinical and Economic Burden of Changing Initial Antifungal Regimens in Invasive Aspergillosis: A Hospital Perspective
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1011) Real-World Antifungal Therapy Patterns in US Patients with Invasive Aspergillosis: It’s Complicated
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT